Jack Chia Industries (Thailand) Public Company (JCT) Fair Value & Analysis
Consumer Defensive · TH · Market cap 1.1B THB
Fair value as of: Jun 24, 2026
Analysis
Jack Chia Industries (Thailand) Public Company (JCT) currently trades at 82.00 THB, while our model-based Fair Value estimate is 147.19 THB — implying the stock looks roughly 79.5% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Jack Chia Industries (Thailand) Public Company Limited, together with its subsidiaries, manufactures and distributes pharmaceutical and cosmetic products in Thailand. The company operates in two segments, Pharmaceutical Products and Other Consumer Products. It offers medical supplies, wound care equipment, sports tapes, and hygiene products under the Tigerplast and Tensoplast brands; cosmetic products comprising perfume, soap, shower gel, powders, etc. under the Tabu brand; eucalyptus health products and household items under the Kangaroo brand; hot compress products under the Thermaplast brand; candy products under the Jason brand; multipurpose lighter fluid products under the Ronsonol brand; and agricultural tape products and cockfighting tapes under the Golden Lion brand. The company was founded in 1966 and is based in Bangkok, Thailand.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Jack Chia Industries (Thailand) Public Company (JCT) undervalued?
What is the fair value of JCT?
What is the quality score of JCT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.